CGH
BEAT

Crossmark Global Holdings’s BioTelemetry, Inc. BEAT Stock Holding History

Crossmark Global Holdings’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,350
Closed -$530K – 1438
2020
Q4 		$530K Buy
+7,350
New +$385K 0.01% 824
2019
Q3 		– Sell
-4,330
Closed -$208K – 1400
2019
Q2 		$208K Sell
4,330
-190
-4% -$9.99K 0.01% 1289
2019
Q1 		$283K Buy
4,520
+40
+0.9% +$2.75K 0.01% 1149
2018
Q4 		$268K Sell
4,480
-12,740
-74% -$765K 0.01% 1145
2018
Q3 		$1.11M Sell
17,220
-560
-3% -$31.2K 0.03% 568
2018
Q2 		$800K Buy
17,780
+910
+5% +$36.3K 0.02% 699
2018
Q1 		$524K Sell
16,870
-790
-4% -$26K 0.01% 891
2017
Q4 		$528K Sell
17,660
-1,960
-10% -$56.8K 0.01% 957
2017
Q3 		$647K Buy
+19,620
New +$680K 0.02% 803
2016
Q3 		$647K Buy
+19,620
New +$370K 0.02% 803

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Crossmark Global Holdings's BEAT Position: Q1 2021 in Review

Crossmark Global Holdings sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 7,350 shares — an estimated $530K sold.

Crossmark Global Holdings first reported a position in BEAT in Q3 2016 and held it in 10 quarters. The position peaked at $1.11M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Crossmark Global Holdings reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Crossmark Global Holdings sold 7,350 BioTelemetry, Inc. shares in Q1 2021, an estimated $530K.
  • Crossmark Global Holdings first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 10 quarters.
  • Crossmark Global Holdings's BioTelemetry, Inc. position peaked at $1.11M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Crossmark Global Holdings's 13F filing for Q1 2021, filed 15 Apr 2021.